Talk:Photodynamic therapy
From Wikipedia, the free encyclopedia
Contents |
[edit] Needs to be revised
"When the photosensitizer and an oxygen molecule are in proximity, an energy transfer can take place that allows the photosensitizer to relax to its ground singlet state, and create an excited singlet state oxygen molecule"
This is only true with some PDT drugs. Newer drugs are composed of dinuclear or trinuclear complexes containing a light absorbing unit, a bridging ligand, and a biologically active site that undergoes metal to metal charge transfer. So when targeted with photons of a certain wavelength the light absorbing unit loses an electron (photoelectric effect?) which travels across the ligand and reduces the metal at the biologically active site and causes the cleavage of DNA. This method of action is completely independant of molecular oxygen and does not produce singlet oxygen in the body.
"...involving three key components: a photosensitizer, light, and tissue oxygen"
"and tissue oxygen" should be removed.
[edit] New treatments in Darwin, Australia
Inventor Terry Wright is currently working on new light arrays for use in PDT. Please see his website at Cytoluminator.com.
[edit] PDT as a method of hair removal
There is nothing in this topic about PDT as a hair removal technology. See [[1]]
[edit] PTD with PPIX mimics Erythropoietic Protoporphyria, not Porphyria cutanea tarda!
In EPP the last step of heme biosynthesis is affected (fixing of iron inside the protoporphyrin IX- ring) which causes PPIX accumulation and reactions to visible light similar seen in PDT. In PCT other heme precursers accumalate (Uroporphyrins, Heptacarboxylporphyrin and Isocoporphyrin), but not PPIX. —Preceding unsigned comment added by 195.176.146.92 (talk) 14:30, 31 March 2008 (UTC)
[edit] Text removed from article
I removed the following text from that article, because it looks like an article abstract that has been dropped into the article without any context. However, I can't find this text on the web: can someone integrate it into the article, if appropriate? -- The Anome (talk) 11:02, 11 May 2008 (UTC)
- Post surgical removal of large tumors PDT can be useful in removing traces of malignant tissue.
- Treatment Regimens
- New protocols that involve refining the timing of photosensitizer delivery and light delivery to maximize photodynamic effect are being sought. Traditional 'acute regimens' are conducted with high doses of photosensitizer and light and may be fractionated to allow for tissue re-oxygenation. Recent studies have introduced the concept of continuous low dose PDT or metronomic PDT. It is proposed that metronomic PDT will preferentially kill cells via apoptosis rather than necrosis which is typically seen following acute regimens and may be important when treating inside the brain for instance. The technologies necessary for metronomic PDT in patients have yet to be made.

